Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Antibody Production and the Role of Inosine "Wobble" in tRNA

    Recent molecular biology research has made significant advances in understanding the complexities of antibody production, highlighting an intriguing aspect of codon usage in this process. This article delves into the findings of Sophie Giguere, a recent Ph.D. graduate from Harvard Medical School, and her work in the Batista lab at the Ragon Institute.

    The Essence of Protein Translation
    Protein production is a critical biological process, varying significantly across different proteins and cell types. Antibodies, essential for fighting infection, are produced in large quantities by B cells. These cells undergo metabolic changes to support this high level of protein synthesis. Giguere's research focuses on the codon usage patterns in antibody sequences and how they compare to those in simpler organisms or different proteins in complex organisms.

    Unraveling the Codon Conundrum in Antibody Sequences
    Giguere's bioinformatic analysis revealed a peculiar characteristic of antibody sequences: the frequent usage of codons that lack a corresponding transfer RNA (tRNA) gene in the genome. This phenomenon, initially a puzzle in genetics, ties back to Francis Crick's concept of tRNA "wobble." This wobble allows tRNAs to translate multiple codons, a concept furthered by the discovery of the "super-wobbler," inosine (I34), which is prevalent in plasma cells producing high antibody levels.

    The Significance of Inosine (I34) in Antibody Production
    The study found an increased efficiency in antibody-producing cells in translating I34-dependent codons. Giguere engineered cell lines to substitute I34-requiring codons with alternatives encoding the same amino acid, observing enhanced efficiency in antibody production. Additionally, in mice with B cell receptors (membrane-bound antibodies) encoded differently but identical as proteins, those with more I34-dependent receptors had a higher survival likelihood.

    Prof. Facundo D. Batista, Ph.D., Associate and Scientific Director of the Ragon Institute, expressed surprise at these findings: “It was surprising to me; the most common codons used in human antibody heavy chains, over and over, were ones with no corresponding tRNA gene in the genome," he said. "I have worked on B cell receptors my entire career, and I had never considered this angle. Every immunologist I spoke to shared a similar reaction.”

    Implications for Antibody Production and Vaccine Efficacy
    This discovery has significant implications for the production of antibodies in laboratories and therapeutics, as well as for vaccine efficacy. Prof. Batista notes, “I spend a lot of time working on which antibodies we want rationally designed vaccines to elicit: now, I will consider how those antibodies are encoded.” The role of the inosine wobble in tRNA, particularly in the context of I34, offers a new perspective in the field of immunology and may pave the way for more efficient antibody production techniques in the future.

Latest Articles

Collapse

  • seqadmin
    The Impact of AI in Genomic Medicine
    by seqadmin



    Artificial intelligence (AI) has evolved from a futuristic vision to a mainstream technology, highlighted by the introduction of tools like OpenAI's ChatGPT and Google's Gemini. In recent years, AI has become increasingly integrated into the field of genomics. This integration has enabled new scientific discoveries while simultaneously raising important ethical questions1. Interviews with two researchers at the center of this intersection provide insightful perspectives into...
    02-26-2024, 02:07 PM
  • seqadmin
    Multiomics Techniques Advancing Disease Research
    by seqadmin


    New and advanced multiomics tools and technologies have opened new avenues of research and markedly enhanced various disciplines such as disease research and precision medicine1. The practice of merging diverse data from various ‘omes increasingly provides a more holistic understanding of biological systems. As Maddison Masaeli, Co-Founder and CEO at Deepcell, aptly noted, “You can't explain biology in its complex form with one modality.”

    A major leap in the field has
    ...
    02-08-2024, 06:33 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, 02-28-2024, 06:12 AM
0 responses
28 views
0 likes
Last Post seqadmin  
Started by seqadmin, 02-23-2024, 04:11 PM
0 responses
74 views
0 likes
Last Post seqadmin  
Started by seqadmin, 02-21-2024, 08:52 AM
0 responses
85 views
0 likes
Last Post seqadmin  
Started by seqadmin, 02-20-2024, 08:57 AM
0 responses
69 views
0 likes
Last Post seqadmin  
Working...
X